added melanoma-derived microvesicles to CD14+ monocytes and observed that the cells retained CD14 status, had HLA-DR (−/low) expression, could not upregulate co-stimulatory molecules, and exhibited an inhibitory function via transforming growth factor (TGF)-β against T cells. This evidence concerns the gene CD14 and melanoma.